A detailed history of Greenfield Savings Bank transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Greenfield Savings Bank holds 11,000 shares of RGC stock, worth $147,840. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$147,840
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

BUY
$15.66 - $877.0 $172,260 - $9.65 Million
11,000 New
11,000 $187,000

Others Institutions Holding RGC

About Regencell Bioscience Holdings Ltd


  • Ticker RGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,012,900
  • Market Cap $175M
  • Description
  • Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...
More about RGC
Track This Portfolio

Track Greenfield Savings Bank Portfolio

Follow Greenfield Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenfield Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Greenfield Savings Bank with notifications on news.